Search Results - "De Cock, Lisa"

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial by De Cock, Lisa, Draulans, Cédric, Pos, Floris J., Isebaert, Sofie, De Roover, Robin, van der Heide, Uulke A., Smeenk, Robert J., Kunze-Busch, Martina, van der Voort van Zyp, Jochem, de Boer, Hans, Kerkmeijer, Linda G.W., Haustermans, Karin

“…•The overall treatment time of focal boosted prostate SBRT can safely be reduced.•No acute grade ≥3 toxicity was reported for the semi-weekly (hypo-FLAME 2.0)…”
Get full text

3396: Focal boost SBRT in men with intermediate- and high-risk PCa: 5-year results of the hypo-FLAME trial by Draulans, Cédric, Haustermans, Karin, Pos, Floris J., van der Heide, Uulke A., De Cock, Lisa, van Zyp, Jochem RN van der Voort, de Boer, Hans C.J., Smeenk, Robert Jan, Kunze-Busch, Martina, Monninkhof, Evelyn M., De Roover, Robin, Isebaert, Sofie, Kerkmeijer, Linda G.W.

Get full text

Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial by Draulans, Cédric, Haustermans, Karin, Pos, Floris J., van der Heide, Uulke A., De Cock, Lisa, van der Voort van Zyp, Jochem, De Boer, Hans, Smeenk, Robert J., Kunze-Busch, Martina, Monninkhof, Evelyn M., De Roover, Robin, Isebaert, Sofie, Kerkmeijer, Linda G.W.

“…[Display omitted] •Prostate SBRT with an integrated focal boost demonstrated excellent 5-year outcomes.•The 5-year bDFS is comparable to that of the focal…”
Get full text